141 related articles for article (PubMed ID: 9122408)
1. MR cholangiopancreatography and MR urography: improved enhancement with a negative oral contrast agent.
Hirohashi S; Hirohashi R; Uchida H; Kitano S; Ono W; Ohishi H; Nakanishi S
Radiology; 1997 Apr; 203(1):281-5. PubMed ID: 9122408
[TBL] [Abstract][Full Text] [Related]
2. Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid.
Kim KA; Kim MJ; Park MS; Lim JS; Choi JY; Hong HS; Kim KW
Radiology; 2010 Aug; 256(2):475-84. PubMed ID: 20656837
[TBL] [Abstract][Full Text] [Related]
3. Thick-section half-Fourier rapid acquisition with relaxation enhancement MR cholangiopancreatography: effects of i.v. administration of gadolinium chelate.
Kanematsu M; Matsuo M; Shiratori Y; Kondo H; Hoshi H; Yasuda I; Moriwaki H
AJR Am J Roentgenol; 2002 Mar; 178(3):755-61. PubMed ID: 11856714
[TBL] [Abstract][Full Text] [Related]
4. [Quality rating of MR-cholangiopancreatography with oral application of iron oxide particles].
Lorenzen M; Wedegärtner U; Fiehler J; Adam G
Rofo; 2003 Jul; 175(7):936-41. PubMed ID: 12847648
[TBL] [Abstract][Full Text] [Related]
5. MR cholangiopancreatography: comparison of images obtained with 1.0 and 1.5 Tesla units.
Yasui M; Ito K; Koike S; Matsunaga N
Radiat Med; 2002; 20(2):77-82. PubMed ID: 12041702
[TBL] [Abstract][Full Text] [Related]
6. [Use of oral superparamagnetic contrast media in cholangiopancreatography with TSE single-shot magnetic resonance].
Blandino A; Gaeta M; Mazziotti S; Settineri N; Pandolfo I
Radiol Med; 1998; 96(1-2):87-91. PubMed ID: 9819624
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of respiratory-triggered fast spin-echo 3 dimensional-MR cholangiopancreatography on middle magnetic field MR imaging].
Isomoto I; Koshiishi T; Uetani M; Hayashi K
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Mar; 57(4):170-5. PubMed ID: 9125872
[TBL] [Abstract][Full Text] [Related]
8. MR cholangiopancreatography (MRCP).
Vrachliotis TG; Shirkhoda A; Bis KG; Shetty AN; Konez O; Ference JJ; Madrazo BL
Crit Rev Diagn Imaging; 1997 Aug; 38(4):295-323. PubMed ID: 9376087
[TBL] [Abstract][Full Text] [Related]
9. [New duct caliber measurement methods on magnetic resonance cholangiopancreatography].
Tamura R; Ishibashi T; Saito H; Majima K; Tsuda M; Takahashi S; Yamada S
Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Nov; 60(13):738-45. PubMed ID: 11140322
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance-cholangiopancreatography in the diagnosis of biliopancreatic diseases.
Lomanto D; Pavone P; Laghi A; Panebianco V; Mazzocchi P; Fiocca F; Lezoche E; Passariello R; Speranza V
Am J Surg; 1997 Jul; 174(1):33-8. PubMed ID: 9240949
[TBL] [Abstract][Full Text] [Related]
11. Periportal contrast enhancement and abnormal signal intensity on state-of-the-art MR images.
Ly JN; Miller FH
AJR Am J Roentgenol; 2001 Apr; 176(4):891-7. PubMed ID: 11264072
[No Abstract] [Full Text] [Related]
12. [Breath hold MR cholangio-pancreatography (MRCP) using long echo train length fast spin echo sequence in combination with surface coil].
Takehara Y; Ichijo K; Tooyama N; Kodaira N; Yamamoto H; Tatami M; Hoshino T; Higuchi T; Dodo S; Watahiki H
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Jul; 53(7):868-70. PubMed ID: 8378151
[TBL] [Abstract][Full Text] [Related]
13. [Demonstration of normal bile duct and pancreatic duct with MR cholangiopancreatography].
Toda J; Ueno E; Takada Y; Okawa T
Nihon Rinsho; 1998 Nov; 56(11):2830-5. PubMed ID: 9847605
[TBL] [Abstract][Full Text] [Related]
14. MR cholangiopancreatography at 3.0 T: intraindividual comparative study with MR cholangiopancreatography at 1.5 T for clinical patients.
Onishi H; Kim T; Hori M; Murakami T; Tatsumi M; Nakaya Y; Nakamoto A; Osuga K; Tomoda K; Nakamura H
Invest Radiol; 2009 Sep; 44(9):559-65. PubMed ID: 19692840
[TBL] [Abstract][Full Text] [Related]
15. MR cholangiopancreatography before and after oral blueberry juice administration.
Papanikolaou N; Karantanas A; Maris T; Gourtsoyiannis N
J Comput Assist Tomogr; 2000; 24(2):229-34. PubMed ID: 10752883
[TBL] [Abstract][Full Text] [Related]
16. Prospective comparative study of negative oral contrast agents for magnetic resonance cholangiopancreatography.
Morita S; Ueno E; Masukawa A; Suzuki K; Fujimura M; Hirabayashi N; Kojima S; Hirata M; Kitajima K; Kaji Y
Jpn J Radiol; 2010 Feb; 28(2):117-22. PubMed ID: 20182846
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced MRI combined with MR cholangiopancreatography for the evaluation of patients with biliary strictures: differentiation of malignant from benign bile duct strictures.
Kim JY; Lee JM; Han JK; Kim SH; Lee JY; Choi JY; Kim SJ; Kim HJ; Kim KH; Choi BI
J Magn Reson Imaging; 2007 Aug; 26(2):304-12. PubMed ID: 17623893
[TBL] [Abstract][Full Text] [Related]
18. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials.
Patten RM; Lo SK; Phillips JJ; Bowman SC; Glazer GM; Wall SD; Bova JG; Harris RD; Wheat RL; Johnson CD
Radiology; 1993 Oct; 189(1):277-83. PubMed ID: 8372205
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance pancreatography.
Barish M; Soto J; Ferrucci J
Endoscopy; 1997 Aug; 29(6):487-95. PubMed ID: 9342566
[TBL] [Abstract][Full Text] [Related]
20. Gadopentetate dimeglumine as an oral negative gastrointestinal contrast agent for MRCP.
Chan JH; Tsui EY; Yuen MK; Szeto ML; Luk SH; Wong KP; Wong NO
Abdom Imaging; 2000; 25(4):405-8. PubMed ID: 10926195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
